Synthesis, structure, docking and cytotoxic studies of ferrocene–hormone conjugates for hormone-dependent breast cancer application

José A. Carmona-Negrón, Alberto Santana, Arnold L. Rheingold and Enrique Meléndez

Dalton Trans., 2019, 48, 5952
DOI: 10.1039/C8DT01856A

Design, Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies of N-(3-Hydroxyindole)-Appended β-Carbolines/Tetrahydro-β-Carbolines Targeting Triple-Negative and Non-Triple-Negative Breast Cancer

Bharvi Sharma, Sourav Taru Saha, Shanen Perumal, Liang Gu, Oluwakemi Ebenezer, Parvesh Singh, Mandeep Kaur and Vipan Kumar

ACS Omega, 2020, 5, 28907
DOI: 10.1021/acsomega.0c01226

Synthesis and in vitro Biological Evaluation of Ferrocenyl Side‐Chain‐Functionalized Paclitaxel Derivatives

Damian Plażuk, Anna Wieczorek, Wojciech M. Ciszewski, Karolina Kowalczyk, Andrzej Błauż, Sylwia Pawlędzio, Anna Makal, Chatchakorn Eurtivong, Homayon J. Arabshahi, Jóhannes Reynisson, Christian G. Hartinger and Błażej Rychlik

ChemMedChem, 2017, 12, 1882
DOI: 10.1002/cmdc.201700576

A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor

Muhammad Hanif, Jahanzaib Arshad, Jonathan W. Astin, Zohaib Rana, Ayesha Zafar, Sanam Movassaghi, Euphemia Leung, Kamal Patel, Tilo Söhnel, Jóhannes Reynisson, Vijayalekshmi Sarojini, Rhonda J. Rosengren, Stephen M. F. Jamieson and Christian G. Hartinger

Angew Chem Int Ed, 2020, 59, 14609
DOI: 10.1002/anie.202005758

Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines

Márton Kalabay, Zsófia Szász, Orsolya Láng, Eszter Lajkó, Éva Pállinger, Cintia Duró, Tamás Jernei, Antal Csámpai, Angéla Takács and László Kőhidai

Pharmaceuticals, 2022, 15, 314
DOI: 10.3390/ph15030314

Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand

Stephen J. Beebe, Michael J. Celestine, Jimmie L. Bullock, Shayna Sandhaus, Jessa Faye Arca, Donald M. Cropek, Tekettay A. Ludvig, Sydney R. Foster, Jasmine S. Clark, Floyd A. Beckford, Criszcele M. Tano, Elizabeth A. Tonsel-White, Raj K. Gurung, Courtney E. Stankavich, Yuk-Ching Tse-Dinh, William L. Jarrett and Alvin A. Holder

Journal of Inorganic Biochemistry, 2020, 203, 110907
DOI: 10.1016/j.jinorgbio.2019.110907

Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships

Ruo Wang, Huahong Chen, Weitao Yan, Mingwen Zheng, Tesen Zhang and Yaohuan Zhang

European Journal of Medicinal Chemistry, 2020, 190, 112109
DOI: 10.1016/j.ejmech.2020.112109

Molecular Mechanism of Action of 2‐Ferrocenyl‐1,1‐diphenylbut‐1‐ene on HL‐60 Leukemia Cells

Alane Cabral de Oliveira, Emanuella Gomes da Silva, Danilo Damasceno Rocha, Elizabeth A. Hillard, Pascal Pigeon, Gérard Jaouen, Felipe A. R. Rodrigues, Fabiane C. de Abreu, Fabrícia da Rocha Ferreira, Marilia O. F. Goulart and Letícia V. Costa‐Lotufo

ChemMedChem, 2014, 9, 2580
DOI: 10.1002/cmdc.201402219

The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells

Mariangela Librizzi, Roberto Chiarelli, Liana Bosco, Supojjanee Sansook, Jose Gascon, John Spencer, Fabio Caradonna and Claudio Luparello

Materials, 2015, 8, 7041
DOI: 10.3390/ma8105358

Ferrocene Derivatives as Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation

Rostislava Angelova and Georgi Stavrakov

Organics, 2025, 6, 4
DOI: 10.3390/org6010004

Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides

Yong Wang, Pascal Pigeon, Siden Top, Michael J. McGlinchey and Gérard Jaouen

Angew Chem Int Ed, 2015, 54, 10230
DOI: 10.1002/anie.201503048

p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes

Solène Topin-Ruiz, Adélie Mellinger, Elise Lepeltier, Clara Bourreau, Juliette Fouillet, Jérémie Riou, Gérard Jaouen, Ludovic Martin, Catherine Passirani and Nicolas Clere

International Journal of Pharmaceutics, 2021, 593, 120111
DOI: 10.1016/j.ijpharm.2020.120111

Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites

Nicolli Bellotti de Souza, Anna Caroline Campos Aguiar, Alane Cabral de Oliveira, Siden Top, Pascal Pigeon, Gérard Jaouen, Marilia Oliveira Fonseca Goulart and Antoniana Ursine Krettli

Mem. Inst. Oswaldo Cruz, 2015, 110, 981
DOI: 10.1590/0074-02760150163

Synthesis and structure–activity relationships of novel hybrid ferrocenyl compounds based on a bicyclic core skeleton for breast cancer therapy

Changhao Li, Chu Tang, Zhiye Hu, Chenxi Zhao, Chenlu Li, Silong Zhang, Chune Dong, Hai-Bing Zhou and Jian Huang

Bioorganic & Medicinal Chemistry, 2016, 24, 3062
DOI: 10.1016/j.bmc.2016.05.019

Hybrid molecules: The privileged scaffolds for various pharmaceuticals

Shaveta, Sahil Mishra and Palwinder Singh

European Journal of Medicinal Chemistry, 2016, 124, 500
DOI: 10.1016/j.ejmech.2016.08.039

Organometallic Nucleoside Analogues with Ferrocenyl Linker Groups: Synthesis and Cancer Cell Line Studies

Huy V. Nguyen, Antoine Sallustrau, Jan Balzarini, Matthew R. Bedford, John C. Eden, Niki Georgousi, Nikolas J. Hodges, Jonathan Kedge, Youcef Mehellou, Chris Tselepis and James H. R. Tucker

J. Med. Chem., 2014, 57, 5817
DOI: 10.1021/jm500246h

Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells

Paul T. Wilder, David J. Weber, Angela Winstead, Sabreea Parnell, Tiara V. Hinton, Monet Stevenson, Dipak Giri, Samira Azemati, Pola Olczak, Brent V. Powell, Tijesunimi Odebode, Solomon Tadesse, Yongchao Zhang, Saroj K. Pramanik, James M. Wachira, Sujan Ghimire, Pumtiwitt McCarthy, Alexis Barfield, Hirendra N. Banerjee, Chao Chen, James A. Golen, Arnold L. Rheingold, Jeanette A. Krause, Douglas M. Ho, Peter Y. Zavalij, Roosevelt Shaw and Santosh K. Mandal

Mol Cell Biochem, 2018, 441, 151
DOI: 10.1007/s11010-017-3181-z

Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides

Yong Wang, Pascal Pigeon, Siden Top, Michael J. McGlinchey and Gérard Jaouen

Angewandte Chemie, 2015, 127, 10368
DOI: 10.1002/ange.201503048

Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors

Laura Cooper, Adam Schafer, Yangfeng Li, Han Cheng, Bani Medegan Fagla, Zhengnan Shen, Raghad Nowar, Katherine Dye, Manu Anantpadma, Robert A. Davey, Gregory R. J. Thatcher, Lijun Rong and Rui Xiong

J. Med. Chem., 2020, 63, 11085
DOI: 10.1021/acs.jmedchem.0c01001

Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds?

Bharvi Sharma and Vipan Kumar

J. Med. Chem., 2021, 64, 16865
DOI: 10.1021/acs.jmedchem.1c00390

Selective Photorelease of an Organometallic-Containing Enzyme Inhibitor

Anna Leonidova, Cristina Mari, Christine Aebersold and Gilles Gasser

Organometallics, 2016, 35, 851
DOI: 10.1021/acs.organomet.6b00029

A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor

Muhammad Hanif, Jahanzaib Arshad, Jonathan W. Astin, Zohaib Rana, Ayesha Zafar, Sanam Movassaghi, Euphemia Leung, Kamal Patel, Tilo Söhnel, Jóhannes Reynisson, Vijayalekshmi Sarojini, Rhonda J. Rosengren, Stephen M. F. Jamieson and Christian G. Hartinger

Angewandte Chemie, 2020, 132, 14717
DOI: 10.1002/ange.202005758

Ferrocene–Biotin Conjugates: Synthesis, Structure, Cytotoxic Activity and Interaction with Avidin

Andrzej Błauż, Błażej Rychlik, Anna Makal, Katarzyna Szulc, Paweł Strzelczyk, Grzegorz Bujacz, Janusz Zakrzewski, Krzysztof Woźniak and Damian Plażuk

ChemPlusChem, 2016, 81, 1191
DOI: 10.1002/cplu.201600320

Development of a Novel Ferrocenyl Histone Deacetylase Inhibitor for Triple-Negative Breast Cancer Therapy

Chu Tang, Yang Du, Qian Liang, Zhen Cheng and Jie Tian

Organometallics, 2018, 37, 2368
DOI: 10.1021/acs.organomet.8b00354